Biotech company Pharming Group NV announces the analyst report completed by Scott R. Henry, CFA from Roth Capital Partners is published.
PHGUF: 2Q17 Recap – Setting Up for 2H17 Ruconest Growth
Visit our Analyst Coverage & Reports page to read more reports by ROTH Capital Partners.
Sijmen de Vries, CEO: T: +31 524 7400
“This update is for informational purposes only and is not viewed by Pharming to be of a price sensitive nature”